CRISPR/Cas-9-mediated targeting of TP53 and MYC to investigate antimitotic mode of action

Saved in:
Bibliographic Details
Published inEuropean journal of cancer (1990) Vol. 61; p. S24
Main Authors Littler, S, Whalley, H, Sousa, S, Taylor, S
Format Journal Article
LanguageEnglish
Published 01.07.2016
Subjects
Hematology, Oncology and Palliative Medicine
Online AccessGet full text

Cover

More Information
ISSN:0959-8049
DOI:10.1016/S0959-8049(16)61073-0